Ovarian cancer drug trial halted: niraparib vs chemo showdown ends early
Disease control
Terminated
This study aimed to see if the drug niraparib works better than standard chemotherapy before surgery for people with advanced (stage III/IV) ovarian cancer that has a specific genetic feature called HRd. The trial was stopped early after enrolling 36 participants. Researchers mea…
Phase: PHASE2 • Sponsor: Tesaro, Inc. • Aim: Disease control
Last updated May 17, 2026 05:33 UTC